BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioForest

  Immune Design Prices $80M Public Offering of Common Stock

  All of the shares of common stock are being offered by Immune Design.

  October 25, 2017

   · 

  4 min read
• Business

  OptiBiotix Signs Supply Agreement With Leading Spanish Pharmaceutical Group for Its Cardiovascular Probiotic Supplement

  OptiBiotix, a world leader in the modulation of the human microbiome, has signed a supply agreement for its cholesterol and blood pressure-reducing probiotic, LPLDL, with the food division of Galenicum Health, a leading Spanish pharmaceutical group.

  October 25, 2017

   · 

  4 min read
• Business

  3D Signatures Reports Financial Results for 2017

  The Company recorded a net loss of $9,913,401 in the year ended June 30, 2017 and $1,758,719 in the year ended June 30, 2016.

  October 25, 2017

   · 

  11 min read
• SYGNIS AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing

  SYGNIS AG today announced the launch of its Universal Lateral Flow Assay (LFA) kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Innova Biosciences brand name.

  October 25, 2017

   · 

  3 min read
• Business

  Dentsply Sirona to Report Third Quarter 2017 Results on November 3rd

  Dentsply Sirona’s management team will host an investor conference call and live webcast at 8:30 am ET that morning.

  October 25, 2017

   · 

  1 min read
• Business

  MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors

  Mr. Wills was appointed to the Company’s Board as a Director in 2017.

  October 25, 2017

   · 

  5 min read
• Business

  Epizyme Announces Date of Third Quarter 2017 Financial Results

  The webcast can be accessed under “Events and Presentations” in the Investor Relations section of the company’s website

  October 25, 2017

   · 

  1 min read
• Ironshore Pharmaceuticals Presents Data From Pivotal Trial at AACAP’S Annual Meeting

  Ironshore Pharmaceuticals & Development, Inc. announced the presentation of new analyses of pivotal trial data for evening-dosed HLD200, also known as DR/ER-MPH (delayed-release and extended-release methylphenidate) at the American Academy of Child and Adolescent Psychiatry (AACAP) annual meeting.

  October 25, 2017

   · 

  4 min read
• Pharm Country

  Creative Biolabs Can Help Reduce Immunogenicity While Remaining the Affinity With Humanized Antibody Germinalization

  Creative Biolabs has successfully developed GHA platform to germinalize humanized antibody production.

  October 25, 2017

   · 

  2 min read
• CorFlow Completes the First Close of the Seed+ Financing Round

  CorFlow Therapeutics AG today announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by experienced private medical device investors who over the last decades have supported breakthrough interventional cardiology technologies.

  October 25, 2017

   · 

  2 min read